US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Roche Holding AG (RHO6) 銘柄情報

Roche Holding AG (RHO6)

45.2526

0.00

( 0.00% )

更新日時： 18:07:31

Roche Holding AG (RHO6) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

45.2526

( - )

買値

45.1859

売値

45.4989

出来高

0.00

0.00 日の範囲 0.00

32.3552 52 週間の範囲 51.40

前日終値

45.2526

始値

-

時刻

最終取引時間

-

平均取引量 (3 か月)

300

財務取引量

-

VWAP

-

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.2151	-2.61493467505	46.4677	46.4677	45.41	708	46.03924931	DE
4	1.4994	3.42694934313	43.7532	46.4677	43.1	321	45.42616141	DE
12	1.8355	4.22759696064	43.4171	46.4677	42.0094	300	44.62576078	DE
26	0.0835	0.184860889413	45.1691	51.4	40.799999	598	47.32296126	DE
52	11.1834	32.825543306	34.0692	51.4	32.3552	532	42.90451343	DE
156	11.888	35.6305785174	33.3646	51.4	27.5	529	37.09822957	DE
260	11.888	35.6305785174	33.3646	51.4	27.5	529	37.09822957	DE

RHO6 - Frequently Asked Questions (FAQ)

What is the current Roche Holding AG share price?

The current share price of Roche Holding AG is 45.2526 €

What is the 1 year trading range for Roche Holding AG share price?

Roche Holding AG has traded in the range of 32.3552 € to 51.40 € during the past year

new-stocks

new-stocks 6分前

https://linktw.in/UQjike

new-stocks

new-stocks 7分前

https://linktw.in/UQjike

new-stocks

new-stocks 7分前

https://linktw.in/UQjike

JRyan

Is ZNOG A Good Investment? An Honest Assessment

https://i.postimg.cc/dV8XpJmX/New-To-ZNOG-Fig1-License-Map.jpg
(Figure 1. The Megiddo-Jezreel License — the single asset on which this entire company depends. ~75,000 acres. License 434 base term expires September 13, 2026.)

north40000

north40000 14分前

Substitute 9% for $19 Billion. ATTR-CM is the heart condition treated with other stabilizers that failed in Phase 3 trial. Has Vascepa been in clinical trials for that condition?

tkg

A good 2:13m video in link...

https://x.com/SanCompounding/status/2074871489476878370

new-stocks

new-stocks 26分前

https://linktw.in/UQjike

new-stocks

new-stocks 26分前

https://linktw.in/UQjike

new-stocks

new-stocks 26分前

https://linktw.in/UQjike

new-stocks

new-stocks 26分前

https://linktw.in/UQjike

new-stocks

new-stocks 27分前

https://linktw.in/UQjike

new-stocks

new-stocks 27分前

https://linktw.in/UQjike

new-stocks

new-stocks 27分前

https://linktw.in/UQjike

new-stocks

new-stocks 28分前

https://linktw.in/UQjike

new-stocks

new-stocks 29分前

https://linktw.in/UQjike

new-stocks

new-stocks 30分前

https://linktw.in/UQjike

new-stocks

new-stocks 31分前

https://linktw.in/UQjike

new-stocks

new-stocks 31分前

https://linktw.in/UQjike

north40000

north40000 41分前

AZN major clinical trial failure/setback with gene-silencing Wainua drug partnered with IONS. AZN stock drops ~ $19 Billion. Bloomberg news is source.

DigitalLeviathan33

DigitalLeviathan33 1時間前

Good article! by ?????

DigitalLeviathan33

DigitalLeviathan33 1時間前

Good article! by [https://welove588.com/]?????[https://welove588.com/] insert-text-here

Franklin BSP Realty

International bond 4.625...

CI Morningstar US Value ...

Bird Construction (PK)

Invesco FTSE Emerging Ma...

Exchange Trading Funds

Ci North American Smallm...

Axia Energia PNB

Investec Bnk 24

Sog_.gdaxi_mf53

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。